Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s shares opened today at $35.16. See what stocks are ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, tisotumab vedotin-tftv, for the treatment of patients ...

JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models in the small-cap biotechnology space. Published ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following ...

Shares of ZLAB opened at $35.39 on Tuesday. Zai Lab has a one year low of $13.48 and a one year high of $36.60. The stock has a 50-day moving average price of $28.10 and a 200 day moving average ...

Shares of Zai Lab Limited Unsponsored ADR (ZLAB) have gained 15.9% over the past four weeks to close the last trading session at $31.73, but there could still be a solid upside left in the stock ...

Fussell was joined by his new productions boss Zai Bennett at yesterday’s BBC Studios Showcase and the pair gave Deadline an insight into short, medium and long-term thinking. For Bennett ...

What are the best MOBAs? You’d be forgiven for thinking that all you had to choose from in the MOBA genre was League of Legends or Dota 2. They’re both behemoths of the gaming landscape and ...